MétaCan
Menu
Back to cohort
Record W2981318929 · doi:10.1016/j.jalz.2019.06.4956

New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures

2019· article· en· W2981318929 on OpenAlexaff
Adam L. Boxer, Michael Gold, Howard Feldman, Bradley F. Boeve, Susan Dickinson, Howard Fillit, Carole Ho, Robert Paul, Rodney Pearlman, Margaret Sutherland, Ajay Verma, Stephen P. Arnerić, Brian M. Alexander, Bradford C. Dickerson, E. Ray Dorsey, Murray Grossman, Edward D. Huey, Michael C. Irizarry, William J. Marks, Mario Masellis, Frances McFarland, Debra Niehoff, Chiadi U. Onyike, Sabrina Paganoni, Michael Panzara, Kenneth Rockwood, Jonathan D. Rohrer, Howard J. Rosen, Robert N. Schuck, Holly Soares, Nadine Tatton

Bibliographic record

VenueAlzheimer s & Dementia · 2019
Typearticle
Languageen
FieldMedicine
TopicAmyotrophic Lateral Sclerosis Research
Canadian institutionsDalhousie UniversityHealth Sciences CentreUniversity of TorontoSunnybrook Health Science Centre
FundersNational Institute of Neurological Disorders and StrokeNational Institute of Mental HealthNational Institute on AgingNational Institutes of HealthAssociation for Frontotemporal Degeneration
KeywordsFrontotemporal lobar degenerationClinical trialFrontotemporal dementiaMedicineBiomarkerModalitiesDementiaPsychologyBioinformaticsPathologyDiseaseBiology

Abstract

fetched live from OpenAlex

INTRODUCTION: Frontotemporal lobar degeneration (FTLD) is the most common form of dementia for those under 60 years of age. Increasing numbers of therapeutics targeting FTLD syndromes are being developed. METHODS: In March 2018, the Association for Frontotemporal Degeneration convened the Frontotemporal Degeneration Study Group meeting in Washington, DC, to discuss advances in the clinical science of FTLD. RESULTS: Challenges exist for conducting clinical trials in FTLD. Two of the greatest challenges are (1) the heterogeneity of FTLD syndromes leading to difficulties in efficiently measuring treatment effects and (2) the rarity of FTLD disorders leading to recruitment challenges. DISCUSSION: New personalized endpoints that are clinically meaningful to individuals and their families should be developed. Personalized approaches to analyzing MRI data, development of new fluid biomarkers and wearable technologies will help to improve the power to detect treatment effects in FTLD clinical trials and enable new, clinical trial designs, possibly leveraged from the experience of oncology trials. A computational visualization and analysis platform that can support novel analyses of combined clinical, genetic, imaging, biomarker data with other novel modalities will be critical to the success of these endeavors.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.007
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.463
Threshold uncertainty score0.720

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0070.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.374
GPT teacher head0.524
Teacher spread0.149 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations67
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicAmyotrophic Lateral Sclerosis ResearchFrench-language works237,207